Hologic Inc
NASDAQ:HOLX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
70.76
83.72
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hologic Inc
Wall Street
Price Targets
HOLX Price Targets Summary
Hologic Inc
According to Wall Street analysts, the average 1-year price target for
HOLX
is 88.53 USD
with a low forecast of 73.24 USD and a high forecast of 99.75 USD.
HOLX Last Price Targets
Hologic Inc
The latest public price target was made on Nov 5, 2024 by
Anthony Petrone
from
Mizuho Securities
,
who expects
HOLX
stock to
rise by 20%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Anthony Petrone
Mizuho Securities
|
87
USD
Upside 20% |
1 month ago
Nov 5, 2024
|
Hologic (HOLX) PT Lowered to $87 at Mizuho
StreetInsider
|
|
Anthony Petrone
Mizuho Securities
|
90
USD
Upside 24% |
2 months ago
Oct 4, 2024
|
Hologic price target raised to $90 from $85 at Mizuho
TheFly
|
Patrick Donnelly
Citigroup
|
85
USD
Upside 17% |
2 months ago
Oct 1, 2024
|
Hologic downgraded to Neutral from Buy at Citi
TheFly
|
Mike Matson
Needham
|
90
USD
Upside 24% |
4 months ago
Jul 30, 2024
|
Hologic Analysts Boost Their Forecasts After Q3 Results
Benzinga
|
Vijay Kumar
Evercore ISI
|
76
USD
Upside 5% |
5 months ago
Jul 2, 2024
|
Hologic price target lowered to $76 from $78 at Evercore ISI
TheFly
|
Ian Zaffino
Oppenheimer
|
33
USD
Downside 55% |
5 months ago
Jun 27, 2024
|
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga
|
David Toung
Argus Research
|
95
USD
Upside 31% |
7 months ago
May 9, 2024
|
Hologic (HOLX) PT Raised to $95 at Argus
StreetInsider
|
Unknown Analyst
Cowen & Co.
|
95
USD
Upside 31% |
1 year ago
Feb 2, 2023
|
Cowen & Co. Maintains Outperform on Hologic, Raises Price Target to $95
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HOLX's stock price target?
Price Target
88.53
USD
According to Wall Street analysts, the average 1-year price target for
HOLX
is 88.53 USD
with a low forecast of 73.24 USD and a high forecast of 99.75 USD.
What is Hologic Inc's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Hologic Inc's revenue is
5%.
The projected
CAGR
for the next 3 years is
6%.
What is Hologic Inc's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Hologic Inc's operating income is
7%.
The projected
CAGR
for the next 3 years is
16%.
What is Hologic Inc's Net Income forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
Hologic Inc's net income is
11%.
The projected
CAGR
for the next 3 years is
15%.
You don't have any saved screeners yet
